Some research suggests that medications like semaglutide could impact intraocular pressure, or IOP, which is an important factor in the development and progression of glaucoma
Reduced Risk of Obesity-Related Conditions: Lowers the chances of developing type 2 diabetes, heart disease, sleep apnea, and other weight-related conditions
Tirzepatide, FDA, and Compounding: Understanding the Current Landscape The removal of tirzepatide from the drug shortage list of the Food and Drug Administration (FDA) list in late 2024 marked a significant turning point for compounders in both 503A and 503B industries
As there is no meaningful expression of GLP-1 receptors on hepatocytes, the major effect of GLP-1 agonists on MASH is likely to be indirect and may be related to a reduction in calorie intake, body weight and insulin resistance, all of which would lead to reduced liver lipid accumulation and hepatic inflammation 7,8
Schedule a consultation and let our board-certified physicians help determine the best treatment plan for your health goals
Primary Research Areas Melanocortin Receptor Pathway Analysis Investigation of MC1R, MC3R, MC4R, and MC5R activation, receptor binding affinity, and cAMP-dependent intracellular signaling mechanisms